Results 141 to 150 of about 169,346 (179)
Some of the next articles are maybe not open access.
Anti-TNF Therapeutics for the Treatment of Sarcoidosis
Immunotherapy, 2014Sarcoidosis is a systemic disease with an incidence of 1 to 40 per 100 000 persons per year. It predominantly affects people in the age of 20 to 40 years old. Disease course varies from mild self-limiting to chronic debilitating and life-threatening disease. Since the cause of sarcoidosis is unknown, curative therapy is not available. Immunosuppressive
Heleen A, Crommelin +5 more
openaire +2 more sources
The ‘Ideal' Anti-TNF Patient: Indications for Anti-TNF Therapy in Crohn's Disease
2015The introduction of anti-TNF monoclonal antibodies to the therapeutic arsenal has represented a major advance in the management of Crohn's disease (CD).
My-Linh Tran-Minh +2 more
openaire +1 more source
Anti - TNF Therapy for Crohns Disease
Current Pharmaceutical Design, 2003Although the cause of Crohn's disease remains unknown considerable progress has been made in recent years to unravel the pathogenesis of the inflammatory processes seen in chronic idiopathic inflammatory bowel diseases (IBD). Th-1 lymphocytes seem to orchestrate the inflammation through the production of pro-inflammatory cytokines such as IFN-gamma, IL-
openaire +2 more sources
Autoimmunity and anti-TNF-alpha agents.
Annals of the New York Academy of Sciences, 2005Treatment of rheumatoid arthritis (RA) patients with anti-tumor necrosis factor-alpha (anti-TNF-alpha) biologic agents has been associated with a reduction in the levels of specific autoantibodies, such as rheumatoid factor (RF) and anticyclic citrullinated peptide (anti-CCP), and the induction of non- organ-specific autoantibodies (antinuclear ...
F. Atzeni +5 more
openaire +2 more sources
The ‘Ideal' Anti-TNF Patient: Indications for Anti-TNF Therapy in Ulcerative Colitis
2015Recently, the efficacy of anti-TNF agents in refractory UC patients has been reported. Promising results of large scale clinical trials encourage us. while we also have unsolved issues in daily practice such as how to evaluate mucosal healing, long-term prognosis of patients treated with anti-TNF agents, and possibility of cessation of anti-TNF agents ...
openaire +1 more source
To (anti-)TNF or not (anti-)TNF? That is the question in pemphigus
British Journal of Dermatology, 2015openaire +2 more sources
Hepatotoxicity of Anti-TNF Agents
Digestive Diseases and Sciences, 2014Maurizio, Bonacini +2 more
openaire +2 more sources
Demyelinating syndrome with the presence of anti-MOG antibodies . A case report
Child Neurology, 2021Paweł Kemnitz +2 more
exaly
Rosyjska „polityka historyczna” wobec Polski. Kwestia „Anty-Katynia”
Krakowskie Studia Małopolskie, 2023Lech Wyszczelski
exaly